Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0001130319-06-000728
Filing Date
2006-08-24
Accepted
2006-08-24 14:04:32
Documents
5
Period of Report
2005-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K/A o32855e10vkza.htm 10-K/A 28464
2 EXHIBIT 31.1 o32855exv31w1.htm EX-31.1 7786
3 EXHIBIT 31.2 o32855exv31w2.htm EX-31.2 7863
4 EXHIBIT 32.1 o32855exv32w1.htm EX-32.1 3363
5 EXHIBIT 32.2 o32855exv32w2.htm EX-32.2 3368
  Complete submission text file 0001130319-06-000728.txt   52290
Mailing Address 50 AUDUBON ROAD SUITE B WAKEFIELD MA 01880
Business Address 50 AUDUBON ROAD SUITE B WAKEFIELD MA 01880 781-224-1444
NUCRYST Pharmaceuticals Corp. (Filer) CIK: 0001344674 (see all company filings)

EIN.: 000000000 | State of Incorp.: A0 | Fiscal Year End: 1231
Type: 10-K/A | Act: 34 | File No.: 000-51686 | Film No.: 061052773
SIC: 3841 Surgical & Medical Instruments & Apparatus